Potencial terapêutico de produtos à base de Cannabis na odontologia: uma análise de literatura
Nenhuma Miniatura disponível
Data
2023-12
Tipo de documento
Monografia
Título da Revista
ISSN da Revista
Título de Volume
Área do conhecimento
Modalidade de acesso
Acesso aberto
Editora
Autores
COSTA, Fabiana Andrade da
HERMOSILLA, Tainá Almada
Orientador
PEREIRA, Jefferson Ricardo
Coorientador
RIGO JUNIOR, Darlan
Resumo
A utilização de produtos à base de cannabis para fins terapêuticos tem emergido como um tópico de crescente interesse e debate em diversas áreas da saúde, incluindo a odontologia. Esta revisão integrativa explorou o potencial terapêutico dos produtos à base de cannabis na odontologia. Destacou-se a longa história de uso da Cannabis sativa L. e sua presença em práticas históricas. A pesquisa abordou propriedades analgésicas, anti-inflamatórias e ansiolíticas dos canabinoides, bem como sua aplicabilidade na higiene bucal. Estudos específicos sobre o canabidiol (CBD) e o canabigerol (CBG) revelaram resultados encorajadores em termos de dor miofascial e atividade anti-biofilme contra S. mutans, respectivamente. No entanto, a revisão apontou para a necessidade de mais pesquisas padronizadas, consenso em dosagens e considerações éticas e legais. A conclusão destaca a promissora eficácia, mas enfatiza a importância da abordagem cautelosa e baseada em evidências na prática odontológica.
The use of cannabis-based products for therapeutic purposes has emerged as a topic of growing interest and debate in several areas of healthcare, including dentistry. This integrative review explored the therapeutic potential of cannabis-based products in dentistry. The long history of use of Cannabis sativa L. and its presence in historical practices were highlighted. The research addressed analgesic, antiinflammatory and anxiolytic properties of cannabinoids, as well as their applicability in oral hygiene. Specific studies on canabidiol (CBD) and cannabigerol (CBG) revealed encouraging results in terms of myofascial pain and anti-biofilm activity against S. mutans, respectively. However, the review pointed to the need for more standardized research, consensus on dosages, and ethical and legal considerations. The conclusion highlights promising efficacy but emphasizes the importance of a cautious, evidencebased approach to dental practice.
The use of cannabis-based products for therapeutic purposes has emerged as a topic of growing interest and debate in several areas of healthcare, including dentistry. This integrative review explored the therapeutic potential of cannabis-based products in dentistry. The long history of use of Cannabis sativa L. and its presence in historical practices were highlighted. The research addressed analgesic, antiinflammatory and anxiolytic properties of cannabinoids, as well as their applicability in oral hygiene. Specific studies on canabidiol (CBD) and cannabigerol (CBG) revealed encouraging results in terms of myofascial pain and anti-biofilm activity against S. mutans, respectively. However, the review pointed to the need for more standardized research, consensus on dosages, and ethical and legal considerations. The conclusion highlights promising efficacy but emphasizes the importance of a cautious, evidencebased approach to dental practice.
Palavras-chave
Cannabis, Cannabinoids, CBD, CBG, Saúde bucal